ArticleACS medicinal chemistry letters2017

Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor.

Young Shin Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.